Who owns TELOMIR PHARMACEUTICALS INC?
- Ticker: TELO
- CUSIP Number: 87975f104
Tip: Access positions for across all investors
Analyze quarterly positions in Telomir Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Telomir Pharmaceuticals stock
Who bought or sold TELOMIR PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.1M | $1.5M | -1% | Sep 2025 |
|
| BlackRock | 291k | $405k | -21% | Sep 2025 |
|
| Millennium Management | 222k | $309k | -10% | Sep 2025 |
|
| Geode Capital Management | 196k | $273k | 0% | Sep 2025 |
|
| Raymond James Financial | 75k | $105k | 4102% | Sep 2025 |
|
| UBS Group | 64k | $88k | 30% | Sep 2025 |
|
| State Street Corporation | 59k | $82k | -5% | Sep 2025 |
|
| Bank of New York Mellon | 52k | $72k | 0% | Sep 2025 |
|
| Suncoast Equity Management | 51k | $71k | 0% | Sep 2025 |
|
| Northern Trust | 42k | $58k | 0% | Sep 2025 |
|
| Morgan Stanley | 25k | $32k | 100% | Jun 2025 |
|
| Advisor Group Holdings | 25k | $33k | 17% | Sep 2025 |
|
| Resources Investment Advisors | 23k | $32k | 64% | Sep 2025 |
|
| Goldman Sachs Group | 23k | $32k | -30% | Sep 2025 |
|
| Praetorian Wealth Management | 20k | $28k | 100% | Sep 2025 |
|
| Mariner Wealth Advisors | 20k | $28k | 100% | Sep 2025 |
|
| Jane Street | 20k | $28k | -60% | Sep 2025 |
|
| Hartland & Co | 13k | $17k | 100% | Sep 2025 |
|
| Qube Research & Technologies | 11k | $15k | -58% | Sep 2025 |
|
| Kestra Private Wealth Services | 11k | $15k | 100% | Sep 2025 |
|
| Regions Bank | 11k | $15k | 100% | Sep 2025 |
|
| Tower Research Capital | 1.3k | $1.7k | -86% | Sep 2025 |
|
| Jones Financial Companies, L.L | 600.00 | $834.000000 | 0% | Sep 2025 |
|
| Royal Bank of Canada | 599.00 | $0 | -37% | Sep 2025 |
|
| EverSource Wealth Advisors | 379.00 | $526.999500 | 724% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 347.00 | $481.983000 | -72% | Sep 2025 |
|
| SRS Capital Advisors | 9.00 | $11.999700 | 100% | Sep 2025 |
|
| SBI Securities | 4.00 | $6.000000 | 0% | Sep 2025 |
|
| CWM | 2.00 | $0 | -100% | Sep 2025 |
|
| Barclays | 2.00 | $3.000000 | -100% | Sep 2025 |
|
Who sold out of Telomir Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Marshall Wace | Jun 2025 | 76k | $95k |
| Y-Intercept | Jun 2025 | 64k | $81k |
| AQR Capital Management | Jun 2025 | 33k | $42k |
| Hrt Financial | Jun 2025 | 29k | $36k |
| Susquehanna International | Jun 2025 | 24k | $30k |
| Two Sigma Securities | Jun 2025 | 23k | $29k |
| Jain Global | Jun 2025 | 16k | $21k |
| Squarepoint Ops | Jun 2025 | 11k | $14k |
| Tactive Advisors | Jun 2025 | 10k | $13k |
| Jpmorgan Chase & Co | Mar 2025 | 9.3k | $30k |
| FMR | Jun 2025 | 5.6k | $7.0k |
| Fortitude Family Office | Jun 2025 | 667.00 | $834.016800 |
| Wells Fargo & Company | Jun 2025 | 149.00 | $185.996700 |
| NISA Investment Advisors | Jun 2025 | 96.00 | $120.000000 |
| Hanson McClain Advisors | Jun 2025 | 12.00 | $15.000000 |
| True Wealth Design | Jun 2025 | 3.00 | $3.999900 |